These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23151220)

  • 1. Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.
    Bánky B; Rásó-Barnett L; Barbai T; Tímár J; Becságh P; Rásó E
    Mol Cancer; 2012 Nov; 11():83. PubMed ID: 23151220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer.
    Givehchian M; Wörner S; Sträter J; Zöller M; Heuschen U; Heuschen G; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Eur J Cancer; 1998 Jun; 34(7):1099-1104. PubMed ID: 9849461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 and the adhesion of neoplastic cells.
    Rudzki Z; Jothy S
    Mol Pathol; 1997 Apr; 50(2):57-71. PubMed ID: 9231152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
    Gotley DC; Fawcett J; Walsh MD; Reeder JA; Simmons DL; Antalis TM
    Br J Cancer; 1996 Aug; 74(3):342-51. PubMed ID: 8695347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
    Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
    Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of a melanoma-specific CD44 alternative splicing pattern that remains qualitatively stable, but shows quantitative changes during tumour progression.
    Raso-Barnett L; Banky B; Barbai T; Becsagh P; Timar J; Raso E
    PLoS One; 2013; 8(1):e53883. PubMed ID: 23342032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
    Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
    Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas.
    Jackson DG; Schenker T; Waibel R; Bell JI; Stahel RA
    Int J Cancer Suppl; 1994; 8():110-5. PubMed ID: 7515025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
    Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
    J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
    Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C
    Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD44 Isoforms in Tumor Samples and Cell Lines of Human Colorectal Cancer.
    Novosad VO; Polikanova IS; Tonevitsky EA; Maltseva DV
    Bull Exp Biol Med; 2022 May; 173(1):155-159. PubMed ID: 35618971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features.
    Zalewski B
    World J Gastroenterol; 2004 Feb; 10(4):583-5. PubMed ID: 14966921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAK alternative splice mRNA variants expression pattern in colorectal cancer.
    Devaud C; Tilkin-Mariamé AF; Vignolle-Vidoni A; Souleres P; Denadai-Souza A; Rolland C; Duthoit C; Blanpied C; Chabot S; Bouillé P; Lluel P; Vergnolle N; Racaud-Sultan C; Ferrand A
    Int J Cancer; 2019 Jul; 145(2):494-502. PubMed ID: 30628725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis.
    Koyama S; Maruyama T; Adachi S
    J Cancer Res Clin Oncol; 1999; 125(1):47-54. PubMed ID: 10037277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 variant expression in cutaneous T-cell lymphoma.
    Orteu CH; Li W; Allen MH; Smith NP; Barker JN; Whittaker SJ
    J Cutan Pathol; 1997 Jul; 24(6):342-9. PubMed ID: 9243361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD44 splice variants during lymphocyte activation and tumor progression.
    Griffioen AW; Horst E; Heider KH; Wielenga VJ; Adolf GR; Herrlich P; Pals ST
    Cell Adhes Commun; 1994 Jul; 2(3):195-200. PubMed ID: 7530151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44 and the pattern of CD44 alternative splicing in uveal melanoma.
    Danen EH; ten Berge PJ; van Muijen GN; Jager MJ; Ruiter DJ
    Melanoma Res; 1996 Feb; 6(1):31-5. PubMed ID: 8640067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multisite and bidirectional exonic splicing enhancer in CD44 alternative exon v3.
    Vela E; Hilari JM; Roca X; Muñoz-Mármol AM; Ariza A; Isamat M
    RNA; 2007 Dec; 13(12):2312-23. PubMed ID: 17940137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 in colon cancer.
    Herrlich P; Pals S; Ponta H
    Eur J Cancer; 1995; 31A(7-8):1110-2. PubMed ID: 7577002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.